Sign in

CIK 0001750284 · Non-accelerated filer<br>Smaller reporting company

Olema Oncology, Inc.

Sign in to watch
Ticker
OLMA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
300409740
Phone
(415) 651-3316
Business address
365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Former names
Olema Pharmaceuticals, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market sale Director sold 10,000 shares at $26.88 ($268,800)
  5. 4 Open-market sale Director sold 3,489 shares at $29.12 ($101,600)
  6. 4 Open-market sale CH. OPERATING & FINANCIAL OFF. sold 103,822 shares at an average $28.70 ($2,980,054)
  7. 4 Open-market sale CH. DISCOV. & NON-CLIN DEV OFF sold 110,000 shares at an average $28.25 ($3,107,229)
  8. 4 Gift President and CEO gave 8,500 shares (gift)
  9. 4 Open-market sale Director sold 2,881 shares at $28.53 ($82,195)
  10. 4 Open-market sale Director sold 264,800 shares at an average $29.73 ($7,873,109)
  11. 4 Open-market sale CH. DISCOV. & NON-CLIN DEV OFF sold 51,000 shares at an average $30.46 ($1,553,544)
  12. 4 Open-market sale Chief Medical Officer sold 269,509 shares at an average $27.94 ($7,530,148)
  13. 4 Gift CH. OPERATING & FINANCIAL OFF. gave 75,000 shares (gift)
  14. 4 Gift CH. OPERATING & FINANCIAL OFF. gave 225,000 shares (gift)
  15. 4 Option exercise Director acquired 35,868 shares (option exercise)
  16. 4 Open-market sale Director sold 25,000 shares at an average $8.19 ($204,841)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 13 · 244 filings